Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections.
Meschiari M, Volpi S, Faltoni M, Dolci G, Orlando G, Franceschini E, Menozzi M, Sarti M, Del Fabro G, Fumarola B, Guarneri F, Lanza P, Lorenzotti S, Saccani B, Signorini L, Van Hauwermeiren E, Gatti M, Pea F, Castelli F, Mussini C.
Meschiari M, et al. Among authors: saccani b.
JAC Antimicrob Resist. 2021 Dec 11;3(4):dlab188. doi: 10.1093/jacamr/dlab188. eCollection 2021 Dec.
JAC Antimicrob Resist. 2021.
PMID: 34909691
Free PMC article.